|
Dr. Pelleg is Duska’s President and Chief Scientific Officer. Dr. Pelleg was a Professor of Medicine and Pharmacology at Drexel University College of Medicine Philadelphia Pennsylvania from 1992 until 2004 and is currently an Adjunct Professor of Medicine at that institution. He is an internationally recognized expert on the physiology and pharmacology of ATP and related compounds in general and their role in the cardiovascular system in particular. His research work has been supported by numerous grants from the National Institutes of Health American Heart Association and pharmaceutical companies. Dr. Pelleg has published more than 100 peer-reviewed papers and edited and co-authored three textbooks in this field. He is a member of the editorial board of The American Journal of Therapeutics and acts as an ad-hoc reviewer for numerous other leading scientific journals. His inventions covered by patents and pending patent applications constitute a significant part of our proprietary technology platform. Dr. Pelleg holds a B.Sc. degree in Biology from Tel-Aviv University M.S. in Bioengineering from the Polytechnic Institute of Brooklyn and a Ph.D. in Physiology from Louisiana State University. He was a NIH post-doctoral fellow at the University of Virginia. | 